TRI-MIX 20MCG+0.5MG+15MG/ML, 10 mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd....
FDA Drug Recall #D-0160-2016 — Class II — October 6, 2015
Recall Summary
| Recall Number | D-0160-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 6, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Chen Shwezin, Inc. dba Park Compounding Pharmacy |
| Location | Westlake Village, CA |
| Product Type | Drugs |
| Quantity | 2 vials |
Product Description
TRI-MIX 20MCG+0.5MG+15MG/ML, 10 mL vial, Rx only, Park Compounding Pharmacy 280 N. Westlake Blvd., Ste. 100 Westlake Village, CA 91362, (805) 497-8258
Reason for Recall
Lack of Assurance of Sterility: all sterile compounded products within expiry
Distribution Pattern
CA
Lot / Code Information
Lot# 09162015@4, Exp, 10/16/15
Other Recalls from Chen Shwezin, Inc. dba Park Compoundi...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0157-2016 | Class II | METHYLCOBALAMIN 1000MCG/ML, 10mL vial, Rx only,... | Oct 6, 2015 |
| D-0159-2016 | Class II | CAFFEINE + SODIUM BENZOATE 500MG/ML, 35 mL vial... | Oct 6, 2015 |
| D-0156-2016 | Class II | PROSTAGLANDIN PGE-1 40MCG/ML, 10mL vial, Rx onl... | Oct 6, 2015 |
| D-0158-2016 | Class II | TRI-MIX 10MCG+0.5MG+15MG/ML,5 mL vial, Rx only,... | Oct 6, 2015 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.